EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention
2015 · European Heart Journal · 154 citations
https://doi.org/10.1093/eurheartj/ehv597